Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging

NCT05043519 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cranial Nerve Injuries

Interventions

DRUG: FAM-NP41

Sponsor

Peking University Third Hospital

Collaborators

[object Object]